❗The content presented here is sourced directly from Coursera platform. For comprehensive course details, including enrollment information, simply click on the 'Go to class' link on our website.

Updated in [July 27th, 2023]

Johns Hopkins University is offering a unique course, PrEParing: PrEP for Providers and Patients, which provides essential information, concepts, and practical advice regarding Pre-Exposure Prophylaxis (PrEP) using the antiretroviral medication emtricitibine/tenofovir. This course is designed to meet the needs of both healthcare workers and PrEP enthusiasts, PrEP users, or the PrEP curious. Healthcare workers will learn about foundational and cutting-edge research and PrEP guidelines, how to initiate a PrEP program, clinical management, and providing culturally sensitive sexual health and primary care to diverse communities. PrEP enthusiasts, PrEP users, or the PrEP curious will learn about who can benefit from PrEP, how to access services, what to expect, and how to stick with their PrEP program long-term. At the conclusion of the session, participants will be able to: 1. Describe the differences between foundational PrEP studies and demonstration projects; 2. Describe the basic pharmacodynamics of tenofovir/emtricitibine including mechanism of infection prevention and time to protective concentration in mucosal tissues; 3. List recommendations from PrEP for Prevention of HIV Infection in the United States clinical practice guidelines, USPHS and CDC, including initial and ongoing screening and testing; 4. Describe the need for PrEP as an HIV prevention tool for priority in often stigmatized populations; 5. Indicate the components for integrating PrEP services into clinical practice; 6. Outline guidelines for screening and treatment of sexually transmitted infections; 7. Describe how to take a thorough sexual history and to engage with clients around sex in an affirming and non-judgmental manner; 8. List the baseline and follow-up laboratory monitoring required; 9. Explain key aspects of patient education for HIV prevention and sexual health; 10. Describe protocols for ongoing PrEP services and when to discontinue. The course is led by a team of experts, including Jason E. Farley, PhD, MPH, ANP-BC, FAAN, Associate Professor at Johns Hopkins University School of Nursing; Chris Beyrer, MD, MPH, Professor at Johns Hopkins University Bloomberg School of Public Health; Yusuf Ariyibi, BA, Disease Intervention Specialist at Baltimore City Health Department; Joyce Jones, MD, MS, Clinical Associate at Johns Hopkins University School of Medicine; Neha Sheth Pandit, PharmD, AAHIVP, BCPS, Associate Professor at University of Maryland School of Pharmacy; Pierre-Cedric Crouch, PhD, ANP-BC, ACRN, Director of Nursing at San Francisco AIDS Foundation; and Renata Arrington Sanders, MD, Assistant Professor at Johns Hopkins.